Skip to main content
. 2010 Nov 3;15(11):7792–7814. doi: 10.3390/molecules15117792

Figure 7.

Figure 7

PKC is a key mediator of EGCG neuroprotection. The schematic shows the effects of PKC activation downstream of EGCG on the processing of APP being skewed towards the nonamyloidogenic product, sAPP, and the phosphorylation and targeting of pro-apoptotic Bad for degradation.